6505--New base plus OY Contract for Nuclear Medicine Radiopharmaceuticals

Sources Sought Notice - MUSKOGEE VAMC NUCLEAR MEDICINE RADIOPHARMACEUTICALS Disclaimer: This Request for Information (RFI) is issued solely for market research information and planning purposes and does not constitute a solicitation. All information received in response to this RFI that is marked as proprietary will be handled accordingly. Responses to this notice are NOT offers and cannot be accepted by the Government to form a binding contract. Responders are solely responsible for all expenses associated with responding to this RFI. Information Requested from Industry: In response to the Sources Sought, interested Contractors shall submit the following information and any Capabilities/Qualifications Statement to include but not limited to an overview of proposed solution(s) and a description of the product your company possesses in accordance with the Statement of Work draft / Salient Characteristics List. Responses to market research table questionnaire shall be submitted. If this information is not provided, then it will be assumed the entire requirement cannot be met. Description of Requirement: The Department of Veterans Affairs, Veterans Health Administration (VHA), Network Contracting Office 19 (NCO 19) is conducting a market survey and is seeking potential sources for Nuclear Medicine Radiopharmaceuticals for the Jack C Montgomery (Muskogee) VA Medical Center. This sources Sought Notice is issued for information and planning purposes only. This is not a solicitation or a request for proposal and shall not be construed as an obligation or commitment by the Government. An award will not be made on any offers submitted in response to this notice, and it shall not be implied the Government is committed to providing any solicitation or award following this notice. The Government will not pay for any information received in response to this request, nor will the Government compensate a respondent for any costs incurred in developing the information provided. Requirement Item OR Services: Item # Product Description         1 Tc-99m Flood ( 2 mCi point source) (daily ) 1 dose     2 Tc-99m Linearity 250 mCi 4 dose     3 Tc-99m Linearity 4 mCi 4 dose     4 Tc-99m Cardiolite 1 dose     5 Tc-99m Sestamibi (generic) 2000 dose     6 Tc-99m MAA 50 dose     7 Tc-99m MAA(110K particles) 10 dose     8 Tc-99m MDP 330 dose     9 Tc-99m HDP 1 dose     10 Tc-99m Mebrofenin 150 dose     11 Tc-99m DTPA GFR 10 dose     12 Tc-99m DTPA Brain 5 dose     13 Tc-99m DTPA CSF 1 dose     14 Tc-99m DTPA Vent 50 dose     15 Tc-99m DMSA 5 dose     16 Tc-99m Mag-3 30 dose     17 Tc-99m Pertechnetate < 50 mCi See below See below     17a 35 mCi 30 dose     17b 30 mCi 5 dose     17c 25 mCi 50 dose     17d 10 mCi 5 dose     17e 5 mCi 5 dose     19 Tc Brain Imaging agent (pricing for only one agent is permissible if contractor cannot supply both agents) See below  See below     19a TC 99m Ceretec (brain) 1 dose     20 Tc-99m Ceretec (WBC) 5 dose     21 Tc-99m Sulfur Colloid filtered 30 dose     22 Tc-99m Sulfur Colloid unfiltered 20 dose     23 Tc-99m Myoview 1 dose     24 Tc-99m Pyrophosphate 1 dose     25 Ga-67 Citrate 10 mCi dose 5 dose     26 I-131 Therapy Capsules/liquid - various doses See below  See below     26a 150 mCi capsule/liquid 1 dose     26b 100 mCi capsule/liquid 1 dose     26c 200 mCi capsule/liquid 3 dose 26d 30 mCi capsule/liquid 10 dose     26e 15 mCi capsule/liquid 10 dose     27 I-131 Diagnostic CAP 10 uCi 5 Dose     28 I-131 WB DOSE 3 mCi dose 5 Dose     29 I-123 CAP (0.1 mCi) 30 Dose     30 I-123 CAP (0.2 mCi) 30 dose     31 In-111 Octreoscan 2 dose     32 In-111 DTPA 5 dose     33 In-111 Oxine (WBC) 20 dose     34 AeroSol Vent Replacement kits (or similar) 60 each     35 Kinevac Vials (when available) 150 vial     36 PYP Vials 50 vial     37 Ultratag 20 vial     38 Ga-67 QC Source 10 uCi 1 dose     39 In-111 QC Source 10 uCi 1 dose     40 I-123 QC Source 10 uCi 1 liquid/solid     41 I-131 QC Source 10 uCi 1 liquid/solid     42 Additional Routine delivery charge (7am-4:30pm) 25 service                   ANCILLARY SUPPLIES Market Quote       43 Cobalt Sheet Source 1 each       price - not included in price of contract Removal of Spent sources also should be included in the price.                     REMOVAL OF RADIOACTIVE WASTE         44 Removal of radioactive waste, including syringes and vials no longer used    All doses coming from pharmacy. Required Salient Characteristics OR SOW Requirements: The Department of Veterans Affairs, VA Medical Center, Muskogee Nuclear Medicine Service requires the contractor to provide the commodity of radiopharmaceuticals and any needed sources to be used with a SPECT & SPECT/CT imaging systems. Vendor must be within local area (50 miles) in order to meet time constraints of delivery requirements. In response to this announcement, please provide the information requested below requested in this market research table questionnaire. If this information is not provided, then it will be assumed the entire requirement cannot be met: NAICS Code: Company Name: Address: UEI (Unique Entity ID) Number: Contact Name: Phone No.: Email: Business Size Information - Select all that applies: Small Business Emerging Small Business Small Disadvantaged Business Certified under Section 8(a) of the Small Business Act HUBZone Woman Owned Certified Service-Disabled Veteran Owned Small Veteran Owned Small Business Large Business FSS/GSA Contract Holder: Yes No FSS/GSA Contract Number: Effective Date/ Expiration Date: Proposed solution is listed and available on the above FSS/GSA Contract: Yes No Available pricing structure of proposed solution: Pricing Model Please Indicate Availability Below: (Yes / No / NA) All on FSS Open Market only Mix of FSS & Open Market Firm-Fixed Price Federal Acquisition Regulation (FAR) Market Rearch Questions: Buy American Act RFO 52.225-1 and RFO 52.225-2 Buy American Certificate What percentage of the proposed product (including leases and rentals) is a: Domestic end product? _____________ (%) Foreign end product? _______________ (%) Country of Origin: Questions for Small Businesses ONLY: Limitations on Subcontracting RFO 52.219-14 What percentage of the work would be subcontracted to another company? ________ What is the business size of the subcontractor?______ Per RFO 52.219-14 the following conditions must be met: Services (except construction), it will not pay more than 50 percent of the amount paid by the Government for contract performance to subcontractors that are not similarly situated entities. Any work that a similarly situated entity further subcontracts will count towards the prime contractor's 50 percent subcontract amount that cannot be exceeded. When a contract includes both services and supplies, the 50 percent limitation shall apply only to the service portion of the contract; Supplies (other than procurement from a nonmanufacturer of such supplies), it will not pay more than 50 percent of the amount paid by the Government for contract performance, excluding the cost of materials, to subcontractors that are not similarly situated entities. Any work that a similarly situated entity further subcontracts will count towards the prime contractor's 50 percent subcontract amount that cannot be exceeded. When a contract includes both supplies and services, the 50 percent limitation shall apply only to the supply portion of the contract; If subcontracting, what added value do you offer (RFO 52.215-23): Nonmanufacturer Rule (RFO 52.219-33): Does your company manufacturer these proposed items? [  ] yes [  ] no Does your company exceed 500 employees? [  ] yes [  ] no If yes, list # of employees: _________ Does your company primarily engaged in the retail or wholesale trade and normally sells the type of item being supplied? [  ] yes [  ] no Does your company take ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice? [  ] yes [  ] no Does your company supply the end item of a small business manufacturer, processor or producer made in the United States, or obtains a waiver of such requirement pursuant to paragraph (b)(5) CFR 121.406. [  ] yes [  ] no If yes, what is the manufacturer s name? ________________ Response Instructions: Do not provide more than 8 pages, including cover letter page. Submit your response via email to barron.long@va.gov Submit your response NLT 10:00 (Central Standard Time Time) on Monday, May 18th, 2026. Mark your response as Proprietary Information if the information is considered business sensitive. VA has identified the appropriate North American Industry Classification System (NAICS) Code as 325412 Pharmaceutical Preparation Manufacturing. With a Small Business size of 1,300 Employees. Please identify and explain any NAICS codes your company believes would better represent the predominant work included in the attached Statement of Need (End of Sources Sought)